Literature DB >> 11035746

Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases.

R G Kansal1, A McGeer, D E Low, A Norrby-Teglund, M Kotb.   

Abstract

The streptococcal cysteine protease (SpeB) is one of the major virulence factors produced by group A streptococci (GAS). In this study we investigated if differences exist in SpeB production by clonally related M1T1 clinical isolates derived from patients with invasive infections. Twenty-nine of these isolates were from nonsevere cases and 48 were from severe cases, including streptococcal toxic shock syndrome (STSS) and necrotizing fasciitis (NF) cases. The expression and amount of the 28-kDa SpeB protein produced were determined by quantitative Western blotting, and protease activity was measured by a fluorescent enzymatic assay. A high degree of variation in SpeB expression was seen among the isolates, and this variation seemed to correlate with the severity and/or clinical manifestation of the invasive infection. The mean amount of 28-kDa SpeB protein and cysteine protease activity produced by isolates from nonsevere cases was significantly higher than that from STSS cases (P = 0.001). This difference was partly due to the fact that 41% of STSS isolates produced little or no SpeB compared to only 14% of isolates recovered in nonsevere cases. Moreover, the cysteine protease activity among those isolates that expressed SpeB was significantly lower for STSS isolates than for isolates from nonsevere cases (P = 0.001). Increased SpeB production was also inversely correlated with intact M protein expression, and inhibition of cysteine protease activity blocked the cleavage of the surface M protein. Together, the data support the existence of both an "on-off" and a posttranslational regulatory mechanism(s) controlling SpeB production, and they suggest that isolates with the speB gene in the "off" state are more likely to spare the surface M protein and to be isolated from cases of severe rather than nonsevere invasive infection. These findings may have important implications for the role of SpeB in host-pathogen interactions via regulation of the expression of GAS virulence genes and the severity of invasive disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11035746      PMCID: PMC97720          DOI: 10.1128/IAI.68.11.6362-6369.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  Absence of SpeB production in virulent large capsular forms of group A streptococcal strain 64.

Authors:  R Raeder; E Harokopakis; S Hollingshead; M D Boyle
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties.

Authors:  R Raeder; M Woischnik; A Podbielski; M D Boyle
Journal:  Res Microbiol       Date:  1998-09       Impact factor: 3.992

3.  A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.

Authors:  W R Lyon; C M Gibson; M G Caparon
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

4.  Comparison of pathogenic factors expressed by group A Streptococci isolated from patients with streptococcal toxic shock syndrome and scarlet fever.

Authors:  M Shiseki; K Miwa; Y Nemoto; H Kato; J Suzuki; K Sekiya; T Murai; T Kikuchi; N Yamashita; K Totsuka; K Ooe; Y Shimizu; T Uchiyama
Journal:  Microb Pathog       Date:  1999-10       Impact factor: 3.738

5.  A two-component regulatory system, CsrR-CsrS, represses expression of three Streptococcus pyogenes virulence factors, hyaluronic acid capsule, streptolysin S, and pyrogenic exotoxin B.

Authors:  A Heath; V J DiRita; N L Barg; N C Engleberg
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Identification of pel, a Streptococcus pyogenes locus that affects both surface and secreted proteins.

Authors:  Z Li; D D Sledjeski; B Kreikemeyer; A Podbielski; M D Boyle
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

7.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.

Authors:  H Basma; A Norrby-Teglund; Y Guedez; A McGeer; D E Low; O El-Ahmedy; B Schwartz; M Kotb
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

8.  Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice.

Authors:  S Lukomski; C A Montgomery; J Rurangirwa; R S Geske; J P Barrish; G J Adams; J M Musser
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin.

Authors:  M Rasmussen; H P Müller; L Björck
Journal:  J Biol Chem       Date:  1999-05-28       Impact factor: 5.157

10.  A response regulator that represses transcription of several virulence operons in the group A streptococcus.

Authors:  M J Federle; K S McIver; J R Scott
Journal:  J Bacteriol       Date:  1999-06       Impact factor: 3.490

View more
  83 in total

Review 1.  Extracellular enzymes with immunomodulating activities: variations on a theme in Streptococcus pyogenes.

Authors:  Mattias Collin; Arne Olsén
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

2.  Role of RopB in growth phase expression of the SpeB cysteine protease of Streptococcus pyogenes.

Authors:  Melody N Neely; William R Lyon; Donna L Runft; Michael Caparon
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

Review 3.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

4.  Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone.

Authors:  Andrew Hollands; Morgan A Pence; Anjuli M Timmer; Sarah R Osvath; Lynne Turnbull; Cynthia B Whitchurch; Mark J Walker; Victor Nizet
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

5.  Ultrahigh and high resolution structures and mutational analysis of monomeric Streptococcus pyogenes SpeB reveal a functional role for the glycine-rich C-terminal loop.

Authors:  Gonzalo E González-Páez; Dennis W Wolan
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

6.  Reciprocal, temporal expression of SpeA and SpeB by invasive M1T1 group a streptococcal isolates in vivo.

Authors:  S U Kazmi; R Kansal; R K Aziz; M Hooshdaran; A Norrby-Teglund; D E Low; A B Halim; M Kotb
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

7.  Group A Streptococcus Infection of the Nasopharynx Requires Proinflammatory Signaling through the Interleukin-1 Receptor.

Authors:  Doris L LaRock; Raedeen Russell; Anders F Johnson; Shyra Wilde; Christopher N LaRock
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

8.  Genetic characterization and virulence role of the RALP3/LSA locus upstream of the streptolysin s operon in invasive M1T1 Group A Streptococcus.

Authors:  Laura A Kwinn; Arya Khosravi; Ramy K Aziz; Anjuli M Timmer; Kelly S Doran; Malak Kotb; Victor Nizet
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

9.  TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens.

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Vivekanand Datta; Xavier Lauth; Randall S Johnson; Victor Nizet
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

10.  Activation of band 3 mediates group A Streptococcus streptolysin S-based beta-haemolysis.

Authors:  Dustin L Higashi; Nicolas Biais; Deborah L Donahue; Jeffrey A Mayfield; Charles R Tessier; Kevin Rodriguez; Brandon L Ashfeld; Jeffrey Luchetti; Victoria A Ploplis; Francis J Castellino; Shaun W Lee
Journal:  Nat Microbiol       Date:  2016-01-18       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.